Search research articles
Contact Us
Filters
Showing results (221-230 of 362) with videos related to
Page
of 37
Sort By:
Antimicrobial Agents and Chemotherapy
|
October 1, 1993
Drug features that contribute to the activity of quinolones against mammalian topoisomerase II and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in vitro and cytotoxic potential
S H Elsea, P R McGuirk, T D Gootz, et al.
Biochemistry
|
August 16, 2006
Polychlorinated biphenyl quinone metabolites poison human topoisomerase IIalpha: altering enzyme function by blocking the N-terminal protein gate
Ryan P Bender, Hans J Lehmler, Larry W Robertson, et al.
Biochemistry
|
March 11, 1997
Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs
S H Elsea, M Westergaard, D A Burden, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1992
Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine group
M J Robinson, B A Martin, T D Gootz, et al.
The Journal of Biological Chemistry
|
June 16, 1995
Sensory and motor neuron-derived factor. A novel heregulin variant highly expressed in sensory and motor neurons
W H Ho, M P Armanini, A Nuijens, et al.
Physical Review Letters
|
August 25, 2004
Interfacial pinning in the superfluid 3He A-B transition in aerogel
J E Baumgardner, Y Lee, D D Osheroff, et al.
Nucleic Acids Research
|
March 6, 2013
Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance
Katie J Aldred, Sylvia A McPherson, Charles L Turnbough, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 22, 2016
Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase
Katie J Aldred, Tim R Blower, Robert J Kerns, et al.
Journal of Biomedical Informatics
|
December 17, 2017
Clinical decision support models and frameworks: Seeking to address research issues underlying implementation successes and failures
Robert A Greenes, David W Bates, Kensaku Kawamoto, et al.
Nature
|
May 21, 2010
A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases
Bryan H Schmidt, Alex B Burgin, Joseph E Deweese, et al.
Page
of 37
Search research articles
Search
Showing results (221-230 of 362) with videos related to
Sort By:
Page
of 37
Antimicrobial Agents and Chemotherapy
|
October 1, 1993
Drug features that contribute to the activity of quinolones against mammalian topoisomerase II and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in vitro and cytotoxic potential
S H Elsea, P R McGuirk, T D Gootz, et al.
Biochemistry
|
August 16, 2006
Polychlorinated biphenyl quinone metabolites poison human topoisomerase IIalpha: altering enzyme function by blocking the N-terminal protein gate
Ryan P Bender, Hans J Lehmler, Larry W Robertson, et al.
Biochemistry
|
March 11, 1997
Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs
S H Elsea, M Westergaard, D A Burden, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1992
Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine group
M J Robinson, B A Martin, T D Gootz, et al.
The Journal of Biological Chemistry
|
June 16, 1995
Sensory and motor neuron-derived factor. A novel heregulin variant highly expressed in sensory and motor neurons
W H Ho, M P Armanini, A Nuijens, et al.
Physical Review Letters
|
August 25, 2004
Interfacial pinning in the superfluid 3He A-B transition in aerogel
J E Baumgardner, Y Lee, D D Osheroff, et al.
Nucleic Acids Research
|
March 6, 2013
Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance
Katie J Aldred, Sylvia A McPherson, Charles L Turnbough, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 22, 2016
Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase
Katie J Aldred, Tim R Blower, Robert J Kerns, et al.
Journal of Biomedical Informatics
|
December 17, 2017
Clinical decision support models and frameworks: Seeking to address research issues underlying implementation successes and failures
Robert A Greenes, David W Bates, Kensaku Kawamoto, et al.
Nature
|
May 21, 2010
A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases
Bryan H Schmidt, Alex B Burgin, Joseph E Deweese, et al.
Page
of 37